Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM

Condition:   Glioblastoma Multiforme Interventions:   Drug: Nivolumab;   Drug: Temozolomide Sponsors:   University of Sydney;   Cooperative Trials Group for Neuro-Oncology;   National Health and Medical Research Council, Australia Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials